Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

about

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q49270446

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@en

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@nl

type

Item

label

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@en

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@nl

prefLabel

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@en

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@nl

P1476

Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

@en

P2093

Jamboor K Vishwanatha

http://www.w3.org/2001/XMLSchema#string

Lee D Gibbs

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer intrinsic subtype classification, clinical use and future trends

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Annexins: from structure to function

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.

Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells.

Triple-negative breast cancer in African-American women: disparities versus biology.

Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling.

P304

2697-2704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23627

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416802

http://www.w3.org/2001/XMLSchema#string

P932

5788670

http://www.w3.org/2001/XMLSchema#string